Novartis Pharmaceuticals Corporation et al v. Lupin Limited et al

DocketCase Assigned to Judge John F. Murphy of the United States District Court for the Eastern District of Pennsylvania. Please include the initials of the Judge (JFM) after the case number on all documents filed. (nmf) (Entered: 05/14/2025)

DocketNo Summons Issued. (mpb) (Entered: 05/12/2025)

Docket(#5) Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis AG, Novartis Pharmaceuticals Corporation. (mpb) (Entered: 05/12/2025)

Docket(#4) Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,492,441; 11,944,602. (mpb) (Entered: 05/12/2025)

Docket(#3) Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: May 10, 2023 (First Notice) and March 25, 2025 (Second Notice). Date of Expiration of Patent: 11/30/2030 for 8,492,441 and 6/24/2036 for 11,944,602.Thirty Month Stay Deadline: N/A. (mpb) (Entered: 05/09/2025)

Docket(#2) Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 05/09/2025)

Docket(#1) COMPLAINT against Lupin Limited, Lupin Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4683180) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibits A-B, #2 Civil Cover Sheet)(mpb) (Entered: 05/09/2025)